探索移植中缺血-再输液损伤的潜在补充调制策略
Dario Troise1,2, Costanza Allegra1, Luciana Antonia Cirolla1
1Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Antioxidants (Basel, Switzerland)
|January 25, 2025
概括
补体系统在缺血-再输液损伤 (IRI) 后有助于移植功能障碍. 本综述探讨了补充向药物,以改善脏IRI管理和移植结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 补体系统对于调节移植期间的炎症反应至关重要.
- 缺血-再输液损伤 (IRI) 显著影响移植结果,并导致移植功能延迟.
- 补充激活,特别是替代途径,驱使IRI病原体在脏区间.
研究的目的:
- 审查补充剂调节药物用于治疗缺血-再输液损伤 (IRI).
- 突出脏移植中向补充因子,受体和调节蛋白的治疗潜力.
主要方法:
- 对补充系统在脏IRI中的作用的文献综述.
- 对当前和研究中的补充调节药物的分析.
- 探索针对补充路径的治疗策略.
主要成果:
- 补充激活会加剧损伤,特别是通过管状上皮细胞功能障碍.
- 几种补充调节药物显示出治疗前景,但缺乏对脏IRI的临床验证.
- 向补充剂为改善脏IRI管理提供了一个潜在的途径.
结论:
- 补体系统是脏IRI和脏移植结果的关键参与者.
- 向补充通路为管理脏IRI提供了一个有希望的策略.
- 需要进一步的研究和临床试验,以建立针对脏IRI的有效补充疗法.
相关概念视频
01:28Kidney Transplant I: Introduction
849
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849
01:26Kidney Transplant II: Surgical Procedure
955
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
955